Raffles Medical Group Ltd (FRA:02M1)
Germany · Delayed Price · Currency is EUR 0.6500
-0.0050 (-0.76%)
At close: Feb 20, 2026
Raffles Medical Group Cash Flow Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 70.57 | 62.24 | 90.15 | 143.21 | 84.17 |
Depreciation & Amortization | 44.56 | 40.75 | 35.98 | 37.88 | 37.1 |
Other Amortization | - | 2.33 | 2.27 | 2.34 | 2.23 |
Loss (Gain) From Sale of Assets | -0 | 1.92 | -0.35 | -0.02 | 0.06 |
Asset Writedown & Restructuring Costs | -2.52 | 3.09 | -7.24 | 19.15 | 4.64 |
Stock-Based Compensation | 3.07 | 3.47 | 3.41 | 3.16 | 2.47 |
Other Operating Activities | -2.55 | -6.31 | -23.82 | 23 | 15.27 |
Change in Accounts Receivable | -7.46 | -28.1 | 95.35 | -32.62 | -48.33 |
Change in Inventory | -0.5 | 1.7 | 0.63 | 0.28 | 1.21 |
Change in Accounts Payable | -3.83 | -1.54 | -37.34 | -6.23 | 61.11 |
Change in Unearned Revenue | - | 6.69 | 30.27 | 6.08 | - |
Change in Other Net Operating Assets | - | - | - | - | 0.17 |
Operating Cash Flow | 101.33 | 86.25 | 189.31 | 196.23 | 160.11 |
Operating Cash Flow Growth | 17.48% | -54.44% | -3.52% | 22.55% | 20.25% |
Capital Expenditures | -7.87 | -19.27 | -20.53 | -25.01 | -49.94 |
Sale of Property, Plant & Equipment | 0.01 | 1.09 | 0.52 | 0.16 | 0.05 |
Sale (Purchase) of Intangibles | -2.16 | -1.64 | -1.41 | -0.29 | -2.86 |
Sale (Purchase) of Real Estate | - | - | - | - | -0.07 |
Other Investing Activities | 7.52 | 9.95 | 9.01 | 2.31 | 0.63 |
Investing Cash Flow | -2.51 | -9.87 | -12.41 | -22.83 | -52.2 |
Long-Term Debt Issued | 1.2 | 67.67 | 110.94 | 85.61 | 47.01 |
Total Debt Issued | 1.2 | 67.67 | 110.94 | 85.61 | 47.01 |
Long-Term Debt Repaid | -46.34 | -92.98 | -122.41 | -192.19 | -51.6 |
Net Debt Issued (Repaid) | -45.13 | -25.31 | -11.47 | -106.58 | -4.58 |
Issuance of Common Stock | 1.12 | 0.28 | 7.44 | 6.03 | 5.6 |
Repurchase of Common Stock | -19.92 | - | -5.7 | -24.34 | -3.23 |
Common Dividends Paid | -46.27 | -44.58 | -70.68 | -52.02 | -37.35 |
Other Financing Activities | -20.65 | -6.6 | -5.12 | -6.8 | -7.31 |
Financing Cash Flow | -130.85 | -76.2 | -85.52 | -183.7 | -46.87 |
Foreign Exchange Rate Adjustments | -0.86 | 0.95 | -0.89 | -1.55 | 0.81 |
Net Cash Flow | -32.88 | 1.13 | 90.49 | -11.85 | 61.85 |
Free Cash Flow | 93.46 | 66.98 | 168.79 | 171.21 | 110.17 |
Free Cash Flow Growth | 39.53% | -60.31% | -1.42% | 55.40% | 48.34% |
Free Cash Flow Margin | 12.13% | 8.90% | 23.84% | 20.75% | 15.19% |
Free Cash Flow Per Share | 0.05 | 0.04 | 0.09 | 0.09 | 0.06 |
Cash Interest Paid | - | 5.03 | 5.12 | 6.8 | 7.31 |
Cash Income Tax Paid | - | 1.16 | 21.14 | 29.15 | 21.74 |
Levered Free Cash Flow | 44.33 | 57.6 | 193.49 | 113.84 | 82.13 |
Unlevered Free Cash Flow | 46.89 | 61.21 | 197.29 | 118.13 | 86.11 |
Change in Working Capital | -11.79 | -21.25 | 88.92 | -32.5 | 14.17 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.